For security reasons, Cigna.com no longer supports your browser version. Please update your browser, or use an alternative browser such as Google Chrome, Microsoft Edge, or Mozilla Firefox for the best Cigna.com experience.
Cigna is dedicated to working closely with customers and health care providers to provide quality preventive health services to improve health outcomes. In 2020, we continued to evolve our customer outreach initiatives to help increase awareness among young adults of the rising incidence of colorectal cancer in this population. Our efforts resulted in 400,000 customers receiving preventive care information on this topic. Additionally, subsequent follow-up revealed that there were undiagnosed colorectal cancers among the targeted population. As a result of our targeted outreach over the past three years, customers under age 50 were screened for, diagnosed, and treated sooner for colon cancer.
Cigna has also signed the "80 percent in Every Community" pledge, sponsored by the National Colorectal Cancer Roundtable. The pledge commits to the goal of 80 percent of adults age 50 and older being regularly screened for colorectal cancer. Since 2018, Cigna achieved and sustained the 80 percent goal in the Maine market, making it one of the few commercial health plans to attain this accomplishment. Cigna is also committed to achieving this goal nationally and has a national program in place to support this effort. Cigna’s quality national colorectal cancer screening program has been recognized by the National Colorectal Cancer Roundtable as a best practice. Established in 2007, the national program has shown statistically significant improvement in screening rates year over year. In 2020, Cigna expanded its offering of at home fecal immunochemical test (FIT) kits. The company tested 9,793 kits, which is more than two-fold increase over the previous year. The increased interest in at-home testing is likely due to the COVID-19 pandemic.